Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Malaria Transmission Intensity Likely Modifies RTS, S/AS01 Efficacy Due to a Rebound Effect in Ghana, Malawi, and Gabon.
Bell GJ, Goel V, Essone P, Dosoo D, Adu B, Mensah BA, Gyaase S, Wiru K, Mougeni F, Osei M, Minsoko P, Sinai C, Niaré K, Juliano JJ, Hudgens M, Ghansah A, Kamthunzi P, Mvalo T, Agnandji ST, Bailey JA, Asante KP, Emch M. Bell GJ, et al. Among authors: adu b. J Infect Dis. 2022 Nov 1;226(9):1646-1656. doi: 10.1093/infdis/jiac322. J Infect Dis. 2022. PMID: 35899811 Free PMC article.
Effect of hookworm infection and anthelmintic treatment on naturally acquired antibody responses against the GMZ2 malaria vaccine candidate and constituent antigens.
Amoani B, Gyan B, Sakyi SA, Abu EK, Nuvor SV, Barnes P, Sarkodie-Addo T, Ahenkorah B, Sewor C, Dwomoh D, Theisen M, Cappello M, Wilson MD, Adu B. Amoani B, et al. Among authors: adu b. BMC Infect Dis. 2021 Apr 8;21(1):332. doi: 10.1186/s12879-021-06027-5. BMC Infect Dis. 2021. PMID: 33832450 Free PMC article.
Extended follow-up of children in a phase2b trial of the GMZ2 malaria vaccine.
Dassah S, Adu B, Sirima SB, Mordmüller B, Ngoa UA, Atuguba F, Arthur FKN, Mensah BA, Kaddumukasa M, Bang P, Kremsner PG, Mategula D, Flach C, Milligan P, Theisen M. Dassah S, et al. Among authors: adu b. Vaccine. 2021 Jul 13;39(31):4314-4319. doi: 10.1016/j.vaccine.2021.06.024. Epub 2021 Jun 24. Vaccine. 2021. PMID: 34175127 Free article. Clinical Trial.
Background malaria incidence and parasitemia during the three-dose RTS,S/AS01 vaccination series do not reduce magnitude of antibody response nor efficacy against the first case of malaria.
Bell GJ, Gyaase S, Goel V, Adu B, Mensah B, Essone P, Dosoo D, Osei M, Niare K, Wiru K, Brandt K, Emch M, Ghansah A, Asante KP, Mvalo T, Agnandji ST, Juliano JJ, Bailey JA. Bell GJ, et al. Among authors: adu b. BMC Infect Dis. 2023 Oct 23;23(1):716. doi: 10.1186/s12879-023-08699-7. BMC Infect Dis. 2023. PMID: 37872492 Free PMC article.
Antibody-Dependent Cellular Inhibition Is Associated With Reduced Risk Against Febrile Malaria in a Longitudinal Cohort Study Involving Ghanaian Children.
Tiendrebeogo RW, Adu B, Singh SK, Dziegiel MH, Nébié I, Sirima SB, Christiansen M, Dodoo D, Theisen M. Tiendrebeogo RW, et al. Among authors: adu b. Open Forum Infect Dis. 2015 Apr 10;2(2):ofv044. doi: 10.1093/ofid/ofv044. eCollection 2015 Apr. Open Forum Infect Dis. 2015. PMID: 26380342 Free PMC article.
72 results